logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

Who pays the DBS fee?

24 June 2013

Last week the Disclosure and Barring Service launched the new online update service which it says can save users millions of pounds a year. Whilst the figures stack up, that claim relies on employees signing up and paying an annual fee.

The online service costs £13 per year for employees compared to a one off fee of £44 for an enhanced criminal records check. The online service also allows employers to check the records regularly, subject to permission from the employee, making the service far more responsive.

But this usefulness is removed if employees choose not to sign up, perhaps because they fail to see the value in a repeat fee when they do not intend to change roles. As subscribing to the service is not compulsory, it is unclear how many will opt to join or indeed who will pay the fee.

What will your school do? Leave it to your staff to decide or perhaps pay the fee so you can benefit from the improved service?

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up